ArticleScientific reports2025
A fusion model to predict the survival of colorectal cancer based on histopathological image and gene mutation.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- Article
- Efficient low-dose CT image enhancement using MobileMamba-UNet with wavelet-enhanced long-range modeling.Journal of applied clinical medical physics · 2026Article
- Nanoparticles: An Emerging Hope in Cancer Therapy.Nanomaterials (Basel, Switzerland) · 2026Review
- A machine learning-based transcriptomic signature for predicting tumor recurrence after curative resection in T1 colorectal cancer: a retrospective multicenter cohort study (The Tw1CE trial).International journal of surgery (London, England) · 2026Article
- Integrating Genomics, Radiomics, and Pathomics in Oncology: A Scoping Review and a Framework for AI-Enabled Surgomics.Bioengineering (Basel, Switzerland) · 2026Review
- A multi-model prediction of a stage-specific prognosis for colorectal cancer using attention-driven deep ensemble learning on genomic profiling data.Frontiers in artificial intelligence · 2026Article
- Nanodynamic Therapy in Colorectal Cancer: Engineering Precision Immunotherapy and Multimodal Synergy.International journal of nanomedicine · 2026Review
- Deciphering the oncogenic role of key genes in HNSC: insights from multi-omics and functional studies.Discover oncology · 2025Article
- Deciphering site-specific histopathological parameters with potential clinical value in head and neck squamous cell carcinomas.Oncology letters · 2025Article
- Integrating image processing with deep convolutional neural networks for gene selection and cancer classification using microarray data.Scientific reports · 2025Article
- Article
- Computational screening of phytochemicals targeting mutant KRAS in colorectal cancer.Scientific reports · 2025Article
- Photoacoustic-Integrated Multimodal Approach for Colorectal Cancer Diagnosis.ACS biomaterials science & engineering · 2025Review
- A branching bivariate weibull distribution model for evaluating exosomes in androgen-deprived agency in the presence of prostate cancer.Scientific reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Colorectal cancer (CRC) is a prevalent gastrointestinal tumor worldwide with high morbidity and mortality. Predicting the survival of CRC patients not only enhances understanding of their life expectancies but also aids clinicians in making informed decisions regarding suitable adjuvant treatments. Although there are many clinical, genomic, and transcriptomic studies on this hot topic, only a few studies have explored the direction of integrating advanced deep learning algorithms and histopathological images. In addition, it is still unclear if combining histopathological images and molecular data can better predict patients' survival. To fill in this gap, we proposed in this study a novel multimodal deep learning computational framework using Multimodal Compact Bilinear Pooling (MCBP) to predict the 5-year survival of CRC patients from histopathological images, clinical information, and molecular data. We applied our framework to the cancer genome atlas (TCGA) CRC data, consisting of 84 samples with histopathological images, clinical information, mRNA sequencing data, and gene mutation data all available. Under the 5-fold cross-validation, the model using only histopathological images achieved an area under the curve (AUC) of 0.743. Whereas, the model combining image and clinical information and the model combining image and gene mutation information achieved AUCs of 0.771 and 0.773 respectively, better than that of the image solely. Our study demonstrates that histopathological images can reasonably predict the 5-year survival of CRC patients, and that the appropriate integration of these images with clinical or molecular data can further enhance predictive performance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.